|
1
|
Forte A, Rinaldi B, Berrino L, Rossi F,
Galderisi U and Cipollaro M: Novel potential targets for prevention
of arterial restenosis: Insights from the pre-clinical research.
Clin Sci (Lond). 127:615–634. 2014. View Article : Google Scholar
|
|
2
|
Dzau VJ, Braun-Dullaeus RC and Sedding DG:
Vascular proliferation and atherosclerosis: New perspectives and
therapeutic strategies. Nat Med. 8:1249–1256. 2002. View Article : Google Scholar
|
|
3
|
Osherov AB, Gotha L, Cheema AN, Qiang B
and Strauss BH: Proteins mediating collagen biosynthesis and
accumulation in arterial repair: Novel targets for anti-restenosis
therapy. Cardiovasc Res. 91:16–26. 2011. View Article : Google Scholar
|
|
4
|
Kumar A, Kumar Singh U and Chaudhary A:
Honokiol analogs: A novel class of anticancer agents targeting cell
signaling pathways and other bioactivities. Future Med Chem.
5:809–829. 2013. View Article : Google Scholar
|
|
5
|
Pan J, Lee Y, Wang Y and You M: Honokiol
targets mitochondria to halt cancer progression and metastasis. Mol
Nutr Food Res. 60:1383–1395. 2016. View Article : Google Scholar
|
|
6
|
Hu H, Zhang XX, Wang YY and Chen SZ:
Honokiol inhibits arterial thrombosis through endothelial cell
protection and stimulation of prostacyclin. Acta Pharmacol Sin.
26:1063–1068. 2005. View Article : Google Scholar
|
|
7
|
Zhang GS, Wang RJ, Zhang HN, Zhang GP, Luo
MS and Luo JD: Effects of chronic treatment with honokiol in
spontaneously hypertensive rats. Biol Pharm Bull. 33:427–431. 2010.
View Article : Google Scholar
|
|
8
|
Fetalvero KM, Martin KA and Hwa J:
Cardioprotective prostacyclin signaling in vascular smooth muscle.
Prostaglandins Other Lipid Mediat. 82:109–118. 2007. View Article : Google Scholar
|
|
9
|
Patel SD, Waltham M, Wadoodi A, Burnand KG
and Smith A: The role of endothelial cells and their progenitors in
intimal hyperplasia. Ther Adv Cardiovasc Dis. 4:129–141. 2010.
View Article : Google Scholar
|
|
10
|
Lee B, Kim CH and Moon SK: Honokiol causes
the p21WAF1-mediated G(1)-phase arrest of the cell cycle through
inducing p38 mitogen activated protein kinase in vascular smooth
muscle cells. FEBS Lett. 580:5177–5184. 2006. View Article : Google Scholar
|
|
11
|
Fan S, Li X, Lin J, Chen S, Shan J and Qi
G: Honokiol inhibits tumor necrosis factor-α-stimulated rat aortic
smooth muscle cell proliferation via caspase- and
mitochondrial-dependent apoptosis. Inflammation. 37:17–26. 2014.
View Article : Google Scholar
|
|
12
|
Seedial SM, Ghosh S, Saunders RS,
Suwanabol PA, Shi X, Liu B and Kent KC: Local drug delivery to
prevent restenosis. J Vasc Surg. 57:1403–1414. 2013. View Article : Google Scholar :
|
|
13
|
Chaudhary MA, Guo LW, Shi X, Chen G, Gong
S, Liu B and Kent KC: Periadventitial drug delivery for the
prevention of intimal hyperplasia following open surgery. J Control
Release. 233:174–180. 2016. View Article : Google Scholar :
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Chen W, Chu Y, Zhu D, Yan C, Liu J, Ji K
and Gao P: Perivascular gene transfer of dominant-negative N19RhoA
attenuates neointimal formation via inhibition of TGF-beta1-Smad2
signaling in rats after carotid artery balloon injury. Biochem
Biophys Res Commun. 389:217–223. 2009. View Article : Google Scholar
|
|
16
|
Suwanabol PA, Kent KC and Liu B: TGF-β and
restenosis revisited: A Smad link. J Surg Res. 167:287–297. 2011.
View Article : Google Scholar :
|
|
17
|
Lu P, Wang S, Cai W and Sheng J: TGF-beta
1/Smad3 expression and its effects on carotid intimal hyperplasia.
Front Biosci (Elite Ed). 4:2022–2028. 2012. View Article : Google Scholar
|
|
18
|
Kamato D, Burch ML, Piva TJ, Rezaei HB,
Rostam MA, Xu S, Zheng W, Little PJ and Osman N: Transforming
growth factor-β signalling: Role and consequences of Smad linker
region phosphorylation. Cell Signal. 25:2017–2024. 2013. View Article : Google Scholar
|
|
19
|
Sartore S, Chiavegato A, Faggin E, Franch
R, Puato M, Ausoni S and Pauletto P: Contribution of adventitial
fibroblasts to neointima formation and vascular remodeling: From
innocent bystander to active participant. Circ Res. 89:1111–1121.
2001. View Article : Google Scholar
|
|
20
|
Luscher TF, Steffel J, Eberli FR, Joner M,
Nakazawa G, Tanner FC and Virmani R: Drug-eluting stent and
coronary thrombosis: Biological mechanisms and clinical
implications. Circulation. 115:1051–1058. 2007. View Article : Google Scholar
|
|
21
|
Chiang CK, Sheu ML, Lin YW, Wu CT, Yang
CC, Chen MW, Hung KY, Wu KD and Liu SH: Honokiol ameliorates renal
fibrosis by inhibiting extracellular matrix and pro-inflammatory
factors in vivo and in vitro. Br J Pharmacol. 163:586–597. 2011.
View Article : Google Scholar :
|
|
22
|
Newby AC: Dual role of matrix
metalloproteinases (matrixins) in intimal thickening and
atherosclerotic plaque rupture. Physiol Rev. 85:1–31. 2005.
View Article : Google Scholar
|
|
23
|
Azevedo A, Prado AF, Antonio RC, Issa JP
and Gerlach RF: Matrix metalloproteinases are involved in
cardiovascular diseases. Basic Clin Pharmacol Toxicol. 115:301–314.
2014. View Article : Google Scholar
|
|
24
|
Jacob MP: Extracellular matrix remodeling
and matrix metalloproteinases in the vascular wall during aging and
in pathological conditions. Biomed Pharmacother. 57:195–202. 2003.
View Article : Google Scholar
|
|
25
|
Ahn KS, Sethi G, Shishodia S, Sung B,
Arbiser JL and Aggarwal BB: Honokiol potentiates apoptosis,
suppresses osteoclastogenesis, and inhibits invasion through
modulation of nuclear factor-kappaB activation pathway. Mol Cancer
Res. 4:621–633. 2006. View Article : Google Scholar
|
|
26
|
Zhang Q, Zhao W, Ye C, Zhuang J, Chang C,
Li Y, Huang X, Shen L, Li Y, Cui Y, et al: Honokiol inhibits
bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget.
6:37335–37348. 2015. View Article : Google Scholar :
|
|
27
|
Kim KR, Park KK, Chun KS and Chung WY:
Honokiol inhibits the progression of collagen-induced arthritis by
reducing levels of pro-inflammatory cytokines and matrix
metalloproteinases and blocking oxidative tissue damage. J
Pharmacol Sci. 114:69–78. 2010. View Article : Google Scholar
|
|
28
|
Chen YJ, Tsai KS, Chan DC, Lan KC, Chen
CF, Yang RS and Liu SH: Honokiol, a low molecular weight natural
product, prevents inflammatory response and cartilage matrix
degradation in human osteoarthritis chondrocytes. J Orthop Res.
32:573–580. 2014. View Article : Google Scholar
|
|
29
|
Zhang YF, Zhou SZ, Cheng XY, Yi B, Shan
SZ, Wang J and Li QF: Baicalein attenuates hypertrophic scar
formation via inhibition of the transforming growth
factor-β/Smad2/3 signalling pathway. Br J Dermatol. 174:120–130.
2016. View Article : Google Scholar
|
